Pharmaceutical Regulatory Affairs & IPR

Regulatory Affairs has a very specific meaning within the healthcare industries. Its regulations are for systematic manufacturing and marketing of safe, efficacious and qualitative drugs. Improving new regulations and adapting to the technology regulatory affairs set new goals and challenges to the pharmaceutical formulation.

The market is expected to expand at a substantial 11.5% CAGR from 2015 to 2023 and rise to a valuation of US$5.7 billion by 2023.

Pharmaceutics 2020 is a global platform to discuss with new innovative techniques, and also learn about research Advances in Drug Targeting and Design, Drug Delivery Research, Pharmaceutical Technology, Novel Drug Delivery Systems, Pre-formulation & formulation studies, Bio pharmaceutics and Biologic Drugs.

• Regulatory Affairs Filing and Documentation
• Enhancing Regulatory Science for Public Health
• Meeting the Challenges for Regulating
• Patent and types of Patent Application
• Copyrights
• Trademark
• Infringement
•  IPRS and Market for Technology
• Role of Patent Co-operation Therapy
•